[Korean Startup Weekly News #113] Mobilint Raises $46.4M Series C, Bets Big on Edge AI

4/12/2026

・

Catch up on last week’s top stories from the startup ecosystem in the Korean Startup Weekly News.

Headline

Mobilint Raises $46.4M Series C, Bets Big on Edge AI with POSCO DX
MOBILINT closes $46.5M Series C and signs an edge AI partnership with POSCO DX, targeting intelligent factory deployment with its in-house NPU tech.

Korea Launches First “Global Basecamp” in the U.S. Southeast to Deepen SME Market Roots
South Korea’s Ministry of SMEs & KOSMES are launching a private-sector-led “Global Basecamp” in the U.S. Southeast — a new model for helping Korean SMEs build lasting market presence abroad. Applications open through April 23.

Check out the latest funding news for Korean startups

People&Technology Raises $10M in SI Bridge Round to Expand Real-Time Patient Monitoring Nationwide
South Korea’s smart hospital platform startup Peoplentech raised $10M in an SI Bridge round, with Dong-A ST joining as a strategic investor. The company targets $13.3M in revenue this year and an IPO in 2027.

AIM Intelligence Raises $7M Series A to Scale AI Security Platform Globally
South Korea’s AIM Intelligence raises $7M Series A led by Samsung Venture Investment to scale its AI security platform globally. Total funding reaches $8.4M.

GreenySystem Raises $6.72M in Strategic Investment to Scale AI-Powered E-Waste Recycling
GreenySystem raises $6.72M (KRW 10B) from global circular economy firm Cimelia to deploy AI-powered e-waste dismantling in South Korea, while achieving R2v3 certification and a first-ever carbon credit transaction in the ITAD sector.

SHAPERON Raises $6.06M via Convertible Bonds to Accelerate Clinical Pipeline and M&A
SHAPERON raises $6.06M (KRW 8.6B) via convertible bonds, bringing total capital to $22.9M. Proceeds target NuGel Phase 2b trials and Nanomab out-licensing.

Brils Raises $4.67M from POSCO Group to Power Group-Wide AX Transformation
POSCO Group invests $4.67M (KRW 7B) in robotics startup Brils to co-develop intelligent factory solutions powered by AI and automation. A KOSDAQ IPO is also on the horizon.

WEFLO Raises $3.65M Series A to Expand AI Diagnostics Into Defense and Global Mobility Markets
South Korea’s Weflo raises $3.65M Series A to scale AI-powered mobility diagnostics into defense & global markets. Total raised: $7.84M.

REVITA Raises Seed Funding to Expand Open-Field Smart Farm Solutions
South Korea’s REVITA raises seed funding from ZD Ventures to scale its open-field smart farm tech — bringing digital agriculture to the 95% of Korean farmland that greenhouses can’t reach.

Feasix AI Raises Seed Funding to Deploy Vision AI Robots Across Outdoor Facility Management
South Korea’s Feasix AI, which uses Vision AI-powered outdoor mobile robots for facility management tasks like parking, cleaning & snow removal, has raised seed funding from Seoul Techno Holdings.

EduSync Secures Seed Funding to Advance Collaborative Learning Platform and Launch AI Teaching Assistant
Korean edtech startup EduSync has raised seed funding from New Paradigm Investment to expand its real-time classroom sync platform KlassMate — with AI-powered lesson tools and global markets on the horizon.

Provally Raises Seed Funding to Cut False Positives in Code Security Analysis
South Korean AI security startup Provally cuts code analysis false positives from 80% to 2% with its AutoProof tool — and just closed a seed round via Bluepoint Partners’ Geek’s School.

Meet startups that are striving for global expansion through exclusive interviews

[Korean Startup Interview] UBITAS Biotech: Pioneering Next-Generation Protein Degradation Technology to Transform Cancer Treatment
UBITAS Biotech is pioneering Protea-Tac, a first-in-class protein degradation platform that eliminates disease-causing proteins without ubiquitin, achieving proven anti-cancer results.

[Korean Startup Interview] BioArchers: Revolutionizing Oral Drug Delivery with NanoLink™ Platform Technology
BioArchers develops NanoLink™, an oral drug delivery platform using mesoporous silica nanoparticles to transform injectable peptide drugs like GLP-1 into once-weekly oral treatments with dramatically improved bioavailability.